Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PRT1419 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Community Based Strategies for Early Detection of Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Long-Term Follow-Up Study of Patients Receiving ATL001
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
BESPOKE Study of ctDNA Guided Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
MElanoma Research Lymph Node Prediction Implementation National_001
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
AI Augmented Training for Skin Specialists
- Status
- COMPLETED
- Phase
- NA
A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
A Study of HX008 for the Treatment of Patients With Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2